ClinicalTrials HQ

Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic Steatohepatitis

Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic Steatohepatitis

Active, not recruiting · NCT05979779 · Registry updated 2025-04-18
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic SteatohepatitisDigestive System Diseases, fatty liver disease, liver disorder, metabolic dysfunction-associated steatohepatitis, metabolic dysfunction-associated steatotic liver diseaseActive, not recruitingPhase 22025-04-18NCT05979779

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Rivus Pharmaceuticals, Inc.2

20 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
ABMED Clinical Research Corp.Cape CoralUnited States1
Advanced Clinical ResearchMiamiUnited States5
Catalina Research InstituteMontclairUnited States7
CenExel HRIBerlinUnited States3
Century Research, LLCMiamiUnited States1
Entrust Clinical ResearchMiamiUnited States11
Houston Research InstituteHoustonUnited States12
IMA Clinical Research-AustinAustinUnited States1
Lillestol ResearchFargoUnited States11
Metro Clinical TrialsSan BernardinoUnited States3
Miami Clinical ResearchMiamiUnited States7
Mt Olympus Medical ResearchHoustonUnited States1
Northern California Research CenterSacramentoUnited States1
Panax Clinical ResearchMiami LakesUnited States10
ProSciento CRUChula VistaUnited States1
Southwest General Healthcare CenterFort MyersUnited States9
Synergy HealthcareBradentonUnited States3
Tandem Clinical ResearchMarreroUnited States24
Texas Liver InstituteSan AntonioUnited States5
Velocity Clinical researchLos AngelesUnited States3